| Covance To Present at the Deutsche Bank 35th Annual Health Care Conference (PR Newswire) Covance Inc. today announced that it will present at the Deutsche Bank 35th Annual Health Care Conference on Tuesday, May 4, 2010 at 1:30 p.m. . Â Investors may access a live webcast of the presentation at www.covance.com. Â In order to register and download any necessary software, please log on 10 minutes early. us.rd.yahoo.com |
Guidelines Would Trim New Doctors' Hours to Reduce Errors Amid continued concern about errors by overworked medical residents, hospitals would be forced to sharply curtail shifts and increase supervision of some doctors-in-training under proposed new guidelines for residency programs. online.wsj.com |
Quest 2Q earnings rise, but outlook pummels shares (AP) Quest Diagnostics reported that second-quarter net income climbed 3 percent, yet the medical laboratory operator cut its annual guidance Wednesday because of falling revenue and shares tumbled 8 percent before the market opened. us.rd.yahoo.com |
Idenix Hopes to Resume Course With Hepatitis C Drugs by Year's End The Burrill Report submits: By Michael FitzhughIdenix Pharmaceuticals (IDIX) halted a mid-stage study of two hepatitis C drugs after the U.S. Food and Drug Administration ordered it to suspend the trial over safety concerns. The news led investors to sink the company's shares on worries about the program's future. Complete Story » seekingalpha.com |
Trius to Participate in Antibiotics Panel Discussion at Citi's 5th Annual Biotech Day [PR Newswire] - Trius Therapeutics, Inc. announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will participate in a panel discussion on antibiotic drug development at Citi's 5th Annual Biotech Day. Â The panel titled, How to Kill Superbugs: Novel Antibiotics to Hit Drug Resistant Bacteria, will take place at 2:00 p.m. us.rd.yahoo.com |